Blood Journals Portfolio/ LinkedIn
Aug 24, 2025, 07:47
Enhao Li on Key Immune Differences Between HA and HB Patients with Inhibitors: B Cells Versus T Cells Dominance
Blood Journals Portfolio shared on X:
“B cells dominate in patients with HA with inhibitors, whereas T cells are relatively more active in those with HB with inhibitors.”
Read the full article here.
Article: Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX
Authors: Enhao Li, Zekun Li, Jinzeng Wang, Haoyang Wu, Yilun Xue, Can Lou, Zhenping Chen, Feng Liu, Wenman Wu, Qiulan Ding, Runhui Wu, Xuefeng Wang, Jing Dai

Keep up with advances in hematology research through Hemostasis Today.
B Cells
Blood Research
Can Lou
Enhao Li
Feng Liu
FIX
FVIII
Haoyang Wu
Health
Hematology
Hemophilia
Hemophilia A
Hemophilia B
Hemostasis
Hemostasis Today
Immune Response
inhibitors
Jing Dai
Jinzeng Wang
Medical Research
Medicine
PBMC
Qiulan Ding
Runhui Wu
Single-Cell Sequencing
T Cells
Wenman Wu
Xuefeng Wang
Yilun Xue
Zekun Li
Zhenping Chen
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
